BriaCell Therapeutics Corp.

NasdaqCM:BCTX Stock Report

Market Cap: US$13.5m

BriaCell Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BCTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Dec 24BuyUS$41,340Marc LustigIndividual2,500US$16.54
17 May 24BuyUS$2,004,516Marc LustigIndividual60,195.7US$33.30
14 May 24BuyUS$2,000,001Marc LustigIndividual60,195.7US$33.22

Insider Trading Volume

Insider Buying: BCTX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies54,5581.47%
Institutions70,5431.9%
Individual Insiders455,61412.3%
General Public3,128,73084.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 248.2%.

Top Shareholders

Top 25 shareholders own 15.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.7%
Marc Lustig
433,454US$1.6m156%no data
1.47%
Copia Fund (Cayman) LP
54,558US$198.2k0%no data
1.08%
Heights Capital Management, Inc.
40,000US$145.3k0%0.04%
0.31%
Jamieson Bondarenko
11,324US$41.1k41.7%no data
0.27%
William Williams
9,976US$36.2k0%no data
0.2%
Vontobel Asset Management, Inc.
7,333US$26.6k37.5%no data
0.13%
Hudson River Trading LLC, Asset Management Arm
4,952US$18.0k0%no data
0.09%
Onyx Bridge Wealth Group LLC
3,333US$12.1k0%no data
0.068%
Group One Trading LP, Asset Management Arm
2,525US$9.2k248%no data
0.063%
BMO Asset Management Corp.
2,355US$8.6k-37.3%no data
0.054%
LPL Financial Corporation, Asset Management Arm
2,017US$7.3k162%no data
0.047%
XTX Holdings Limited, Asset Management Arm
1,761US$6.4k114%no data
0.044%
HighTower Advisors, LLC
1,641US$6.0k68.3%no data
0.029%
Cambridge Investment Research Advisors, Inc.
1,086US$3.9k0%no data
0.025%
Susquehanna International Group, LLP, Asset Management Arm
926US$3.4k12.5%no data
0.017%
Vaughn Embro-Pantalony
635US$2.3k0%no data
0.014%
National Bank Investments Inc.
519US$1.9k3.8%no data
0.013%
Geode Capital Management, LLC
481US$1.7k-2.83%no data
0.009%
SBI Holdings Inc., Asset Management Arm
333US$1.2k0%no data
0.009%
Concord Wealth Partners
333US$1.2k-64.5%no data
0.0069%
RBC Dominion Securities Inc., Asset Management Arm
254US$923.0-0.39%no data
0.0051%
Toronto-Dominion Bank, Banking Investments
190US$689.9-17.4%no data
0.005%
Gadi Levin
187US$679.10%no data
0.0048%
Morgan Stanley, Investment Banking and Brokerage Investments
177US$642.70%no data
0.0027%
FNY Investment Advisers, LLC
100US$363.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 10:29
End of Day Share Price 2025/02/11 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BriaCell Therapeutics Corp. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily BodnarH.C. Wainwright & Co.
Ashok KumarThinkEquity LLC